$GLMD
Galmed Pharmaceuticals Ltd
PRICE
$0.5 ▲3.627%
Extented Hours
VOLUME
21,890
DAY RANGE
0.46 - 0.5
52 WEEK
0.4167 - 3.42
Key Metrics
Market Cap
12.39 M
Beta
0.95
Avg. Volume
87.43 K
Shares Outstanding
25.09 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-04
Next Dividend Date
Company Information
Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Its lead compound, Aramchol™, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study.It is also collaborating with the Hebrew University in the development of Amilo-5MER, a 5 amino acid synthetic peptide and plan to initiate a first in human study by the first quarter of 2021.
CEO: Allen Baharaff
Website: galmedpharma.com
HQ: 16 Zeev Tyomkin St 4th Fl, 6578317 Tel Aviv Yafo
Related News